ATH 33.3% 0.4¢ alterity therapeutics limited

Unfortunately, I have little insight into how future trials may...

  1. 114 Posts.
    Unfortunately, I have little insight into how future trials may turn out.  I believe that nearly every neurodegenerative disease is primarily driven by oxidation.  The parts of the brain affected, the types of neurons affected, and the speed and degree of damage may differ, but not so much the cause.

    http://www.sciencedirect.com/science/article/pii/S0306452205006895

    If you remove copper and zinc from around NMDA receptors, you slow down the damage, but how much and for how long is not known yet.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.